STAA•benzinga•
Eye Lens Maker Staar Surgical Stock Sinks As Sales Drop To $49 Million, Analyst Downgrades
Summary
Staar Surgical posted a Q4 2024 revenue decline due to weak China sales. The company plans cost-cutting measures.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 12, 2025 by benzinga